| Literature DB >> 35211413 |
Laura M O'Connor1,2, Jae H Choi1,3, Jason A Dowling4, Helen Warren-Forward2, Jarad Martin1,5, Peter B Greer1,3.
Abstract
PURPOSE: There are several means of synthetic computed tomography (sCT) generation for magnetic resonance imaging (MRI)-only planning; however, much of the research omits large pelvic treatment regions and female anatomical specific methods. This research aimed to apply four of the most popular methods of sCT creation to facilitate MRI-only radiotherapy treatment planning for male and female anorectal and gynecological neoplasms. sCT methods were validated against conventional computed tomography (CT), with regard to Hounsfield unit (HU) estimation and plan dosimetry. METHODS AND MATERIALS: Paired MRI and CT scans of 40 patients were used for sCT generation and validation. Bulk density assignment, tissue class density assignment, hybrid atlas, and deep learning sCT generation methods were applied to all 40 patients. Dosimetric accuracy was assessed by dose difference at reference point, dose volume histogram (DVH) parameters, and 3D gamma dose comparison. HU estimation was assessed by mean error and mean absolute error in HU value between each sCT and CT.Entities:
Keywords: MRI radiotherapy planning; anal canal neoplasms; cervix neoplasms; computer-assisted radiotherapy planning; endometrium neoplasms; image-guided radiotherapy; rectum neoplasms; synthetic CT
Year: 2022 PMID: 35211413 PMCID: PMC8861348 DOI: 10.3389/fonc.2022.822687
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
MRI acquisition parameters.
| Parameter | T1 VIBE Dixon |
|---|---|
| Scan type | VIBE Dixon |
| TE (ms) | 1.23/2.46 |
| TR (ms) | 4.19 |
| Flip angle (°) | 9 |
| FOV (mm) | 256 * 499 |
| Slice thickness (mm) | 1.6 |
| Base resolution | 160 |
| Acquisition plane | Coronal |
| Phase direction | R>L |
| Bandwidth (Hz/px) | 1,200 |
| Fat-water shift (px) | 0.3 |
| Distortion correction | 3D |
| Acquisition stages | 2 |
| Overlap (mm) | 48 |
| Composing | Inline |
Figure 1Generator architecture. Note that the number of filters (i.e., 64 filters) indicates the number of filters in each convolutional layer.
Patient demographics.
| Cohort size | Age range | BMI range (kg/m2) | Relevant surgical history | Primary treatment site | Staging range | |
|---|---|---|---|---|---|---|
|
| 20 | 49–88 (mean = 65) | 20.5–33.6 (mean = 25.5) | Hernia repairs ( | Rectum ( | T1N0–T4N1 |
|
| 20 | 41–85 (mean = 61) | 18.0–36.9 (mean = 26.2) | Hysterectomy ( | Rectum ( | T3N0–T3N2 |
| Anal canal ( | T1N0–T3N1 | |||||
| Cervix ( | IIA–IIB | |||||
| Endometrium ( | IIIA–IIIC |
Figure 2CT and sCT scans (with corresponding MRI) with treatment plan calculated and dose color wash displayed. Column (A) T1 in-phase-stitched T1 VIBE Dixon; column (B) original CT scan column; column (C) deep learning-generated sCT; column (D) hybrid atlas-generated sCT; column (E) tissue class density assignment sCT (three tissue classes); and column (F) bulk density overrides sCT.
ICRU median percentage dose difference and median DVH dose difference by the sCT method.
| ICRU %DD | DVH %DD | Mean absolute error (HU) | Mean error (HU) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Median (IQR) |
| Median (IQR) |
| Whole body | Bone | Soft tissue | Whole body | Bone | Soft tissue | |
|
| −0.03 (0.13, −0.31) | 1.00 | 0.18 (0.40, −0.05) | 0.93 | 34.7 ± 5.1 | 109.4 ± 12.3 | 25.2 ± 3.4 | −2.5 ± 5.8 | −46.0 ± 19.6 | −0.7 ± 6.3 |
|
| −0.30 (−0.02, −0.57) | 0.82 | −0.27 (0.12, −0.77) | 0.76 | 57.4 ± 8.0 | 186.9 ± 17.9 | 47.3 ± 7.8 | −2.0 ± 9.0 | −78.0 ± 35.3 | 4.1 ± 8.5 |
|
| −0.48 (−0.28, −0.85) | 0.68 | −0.48 (0.11, −0.66) | 0.71 | 58.8 ± 10.4 | 228.2 ± 11.2 | 44.6 ± 8.5 | −9.8 ± 7.3 | −25.8 ± 39.7 | −8.6 ± 7.5 |
|
| −0.73 (−0.10, −1.01) | 0.64 | −0.33 (0.19, −0.67) | 0.70 | 89.1 ± 7.7 | 244.1 ± 10.0 | 76.1 ± 6.7 | 8.0 ± 13.7 | 5.7 ± 39.3 | 7.8 ± 14.7 |
Mean absolute error and mean error in whole body and bone HU ± 1 SD by the sCT method.
Figure 3Percentage DVH dose difference by structure (each structure parameter combined) for each synthetic CT method.
3D gamma dose comparison for each sCT technique (mean ± 1 SD).
| 3%/2 mm | 2%/2 mm | 1%/1 mm | |||||
|---|---|---|---|---|---|---|---|
| Pass rate (%) | Average gamma | Pass rate (%) | Average gamma | Pass rate (%) | Average gamma | ||
| Deep learning | All | 99.8 ± 0.3 | 0.09 ± 0.02 | 99.7 ± 0.4 | 0.14 ± 0.03 | 97.3 ± 2.0 | 0.28 ± 0.07 |
| Female | 99.8 ± 0.3 | 0.10 ± 0.02 | 99.6 ± 0.4 | 0.14 ± 0.03 | 97.4 ± 1.2 | 0.28 ± 0.06 | |
| Male | 99.9 ± 0.3 | 0.09 ± 0.03 | 99.7 ± 0.4 | 0.14 ± 0.03 | 97.1 ± 2.5 | 0.27 ± 0.08 | |
| Hybrid atlas | All | 99.8 ± 0.3 | 0.12 ± 0.04 | 99.7 ± 0.3 | 0.17 ± 0.05 | 94.8 ± 4.5 | 0.35 ± 0.11 |
| Female | 99.8 ± 0.3 | 0.13 ± 0.04 | 99.7 ± 0.4 | 0.19 ± 0.06 | 93.4 ± 5.2 | 0.38 ± 0.12 | |
| Male | 99.8 ± 0.2 | 0.10 ± 0.03 | 99.7 ± 0.3 | 0.15 ± 0.04 | 96.3 ± 3.2 | 0.31 ± 0.09 | |
| Tissue class | All | 99.8 ± 0.3 | 0.12 ± 0.03 | 99.7 ± 0.4 | 0.18 ± 0.04 | 95.3 ± 3.3 | 0.35 ± 0.08 |
| Female | 99.8 ± 0.3 | 0.12 ± 0.02 | 99.7 ± 0.4 | 0.18 ± 0.03 | 95.2 ± 3.1 | 0.36 ± 0.07 | |
| Male | 99.9 ± 0.2 | 0.12 ± 0.03 | 99.7 ± 0.4 | 0.17 ± 0.04 | 95.4 ± 3.2 | 0.34 ± 0.09 | |
| Bulk density | All | 99.8 ± 0.3 | 0.14 ± 0.03 | 99.7 ± 0.4 | 0.19 ± 0.05 | 93.6 ± 3.8 | 0.38 ± 0.09 |
| Female | 99.8 ± 0.4 | 0.12 ± 0.03 | 99.6 ± 0.4 | 0.17 ± 0.05 | 95.1 ± 3.3 | 0.34 ± 0.09 | |
| Male | 99.9 ± 0.2 | 0.13 ± 0.03 | 99.7 ± 0.4 | 0.21 ± 0.05 | 92.1 ± 3.6 | 0.42 ± 0.09 | |